Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2006-08-29
2006-08-29
Badio, Barbara P. (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
C514S182000
Reexamination Certificate
active
07098199
ABSTRACT:
A method of inhibiting steroid sulphatase activity in a subject in need of same is described.The method comprises administering to said subject a steroid sulphatase inhibiting amount of a ring system compound; which ring system compound comprises a ring to which is attached a sulphamate group of the formulawherein each of R1and R2is independently selected from H, alkyl, alkenyl, cycloalkyl and aryl, or together represent alkylene optionally containing one or more hetero atoms or groups in the alkylene chain; and wherein said compound is an inhibitor of an enzyme having steroid sulphatase activity (E.C.3.1.6.2); and if the sulphamate group of said compound is replaced with a sulphate group to form a sulphate compound and incubated with a steroid sulphatase enzyme (E.C.3.1.6.2) at a pH 7.4 and 37° C. it would provide a Kmvalue of less than 50 μM.
REFERENCES:
patent: 2839562 (1958-06-01), Wegler et al.
patent: 3082238 (1963-03-01), Hirsch
patent: 3661830 (1972-05-01), Feit et al.
patent: 3909924 (1975-10-01), Vindasius et al.
patent: 3950380 (1976-04-01), Feit et al.
patent: 3997585 (1976-12-01), Hirsch
patent: 4003127 (1977-01-01), Jaffe et al.
patent: 4061663 (1977-12-01), Hirsch
patent: 4075351 (1978-02-01), Hirsch
patent: 4219494 (1980-08-01), Fischer et al.
patent: 4222767 (1980-09-01), Gates et al.
patent: 4513006 (1985-04-01), Maryanoff et al.
patent: 4582916 (1986-04-01), Maryanoff et al.
patent: 4591601 (1986-05-01), Maryanoff et al.
patent: 4665610 (1987-05-01), Barth
patent: 4670969 (1987-06-01), Yamada et al.
patent: 4699006 (1987-10-01), Boxenhorn
patent: 4792569 (1988-12-01), Maryanoff et al.
patent: 4824475 (1989-04-01), Markley et al.
patent: 4826528 (1989-05-01), Mengel et al.
patent: 4900727 (1990-02-01), Kattige et al.
patent: 4937237 (1990-06-01), Holt et al.
patent: 4948456 (1990-08-01), Schubert
patent: 5025031 (1991-06-01), Lo et al.
patent: 5151763 (1992-09-01), Marek et al.
patent: 5192785 (1993-03-01), Lo et al.
patent: 5194402 (1993-03-01), Ehfeld et al.
patent: 5194446 (1993-03-01), Lo et al.
patent: 5273993 (1993-12-01), Lo et al.
patent: 5281587 (1994-01-01), Reed
patent: 5344827 (1994-09-01), Reed
patent: 5360754 (1994-11-01), Pribat et al.
patent: 5604215 (1997-02-01), Reed et al.
patent: 5616574 (1997-04-01), Reed et al.
patent: 5677292 (1997-10-01), Li et al.
patent: 5830886 (1998-11-01), Reed et al.
patent: 6159960 (2000-12-01), Reed et al.
patent: 645975 (1994-02-01), None
patent: 2417764(A1) (1974-04-01), None
patent: 1471174 (1974-07-01), None
patent: 2531445(A1) (1975-07-01), None
patent: 24 18 217 (1975-11-01), None
patent: 1524727 (1975-11-01), None
patent: 2559210(A1) (1975-12-01), None
patent: 2025397 (1979-05-01), None
patent: 207447 (1982-02-01), None
patent: 4000903 (1990-08-01), None
patent: 4003473 (1991-09-01), None
patent: 0357061 (1989-08-01), None
patent: 0359036 (1989-08-01), None
patent: 0682020 (1989-08-01), None
patent: 0 403 185 (1990-12-01), None
patent: 2133484 (1972-12-01), None
patent: 1 554 976(A) (1978-12-01), None
patent: 1 398 026 (1975-06-01), None
patent: 50-13530 (1974-05-01), None
patent: 50-32160 (1974-07-01), None
patent: 50-32161 (1974-07-01), None
patent: 50-101533 (1974-12-01), None
patent: 62-242680 (1987-10-01), None
patent: 37270 (1989-08-01), None
patent: DD 114 806 (1975-08-01), None
patent: DD 114806 (1975-08-01), None
patent: WO 92/03740 (1992-03-01), None
patent: WO 97/30041 (1997-08-01), None
patent: WO 97/32872 (1997-09-01), None
patent: WO 98/24802 (1998-06-01), None
patent: WO 0104086 (2000-07-01), None
Registry Handbook, 1984 Supplement.
“Tierexperimenteller Beitrag zur Entwicklung Estrogener Wirkstoffe,” Dissertation sur Erlangung des akademischen Grades eines Doktors der Wissenschaften an der Mathematisch-Naturwissenschaftlich-Technischen Fakultät des Wissenschaftlichen Rates der Friedrich-Schiller-Universität Jena, Wolfgang Stölzner, Jena, Germany, Aug. 1988 (hereinafter, “the Stölzner Dissertation”).
“Erythrozyten als Arzneimittelträger—Untersuchungen mit ausgewählten Estrogenen zur Beladung nach oraler Gabe,” Dissertation B sur Erlangung des akademischen Grades eines Doktors der Wissenschaften, Der Fakultät für Naturwissenschaftlichen Rates der Martin-Luther-Universität Halle-Wittenberg, Claus Clauβn, Jena, Germany, Aug. 1989 (hereinaftēr “the Clauβen Dissertation”).
Spillane and Burke, Synthesis, 12 (pp. 1021-1024), 1986.
Erythrocytes as a drug carrier—Investigations with selected estrogens for loading following oral administration, Natural Science Faculty, Science Council, Martin-Luther Unversitat Halle-Wittenberg, Germany, Aug. 1989.
Woo L W L et al. “Steroidal and nonsteroidal sulfamates as potent inhibitors of steroid sulfatase” Journal of Medicinal Chemistry, American Chemical Society, Washington, US, vol. 41, No. 7, Mar. 1998.
Hedayatallah and Hugeny, Phosphorus and Sulfer, vol. 20 (pp. 371-375) 1984.
Stoler “Animal Experimental Contribution to the Development of Estrogenic Substances”, Dissertation for award of Doctor of Science degree at the Mathematic-Naturwissenschaftlichh-Technischen faculty of Friedrich-Schiller-University Jena, Jul. 1989.
Schwarz et al., Pharmazie, vol. 30(1) (1975), pp. 17-21.
Howarth et al., J. Med. Chem., vol. 37 (1994), pp. 219-221.
Schwartz S et al. “Steroidsulfamate” Zeitschrift Fur Chemie, vol. 14, No. 1, 1974, pp. 15-16.
Townsley et al., Research Steroids, vol. 5 (1973), pp. 73-78.
Spillane et al., J. Chem. Soc., Perk. Trans. I, (3), (pp. 677-679) 1982.
Weiss and Schulze, Liebigs Ann.Chem. 729, (pp. 40-51) 1969.
Usov, ISV. Akad. Nauk, SSSR, Ser. Khim., (s), (CA 83.131847t) (pp. 1084-1088) 1975.
Lohaus Chem.. Ber., 105, (pp. 2791-2799), 1972(in German).
Maryanoff et al., J. Med. Chem, 30 (pp. 880-887) 1987.
Walsh et al., J. Med. Chem, 33 (pp. 2068-2070) 1990.
Dubois et al., J. Org. Chem. vol. 45, No. 26, (pp. 5372-5375) 1980.
V.H.T. James et al., Aromatase Activity In Normal Breast And Breast Tumor Tissues: In Vivo And Inc Vitro Studies, Steroids (1987): 50 pp. 269-279.
Lloyd Potter Barry Victor
Reed Michael John
Badio Barbara P.
Collison Angela M.
Frommer & Lawrence & Haug LLP
Kowalski Thomas J.
Sterix Limited
LandOfFree
Steroid sulphatase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Steroid sulphatase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Steroid sulphatase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3690834